PIASy interacts with p73α and regulates cell cycle in HEK293 cells

Cellular Immunology

Volumn 263, Issue 2, 2010, Pages 235-240

  Zhang, Chao ^a   Yuan, Xia ^a   Yue, Ling ^a   Fu, Jin ^a   Luo, Lan ^b   Yin, Zhimin ^a  

^a NANJING NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Cell cycle; P73; PIAS SUMO ligase; PIASy; Sumoylation

Indexed keywords

PROTEASOME; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT Y; PROTEIN P21; PROTEIN P73; PROTEIN P73 ALPHA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NUCLEAR PROTEIN; SUMO PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REENTRY; CELL CYCLE REGULATION; CELL STRAIN HEK293; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SUMOYLATION; TRANSCRIPTION REGULATION; CELL CYCLE; CELL LINE; GENE EXPRESSION; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL CYCLE; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN PROCESSING, POST-TRANSLATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 77953360525     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.04.005     Document Type: Article

References (38)

1. Shuai K., Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 2005, 5:593-605.
2. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science 1997, 278:1803-1805.
3. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 1998, 95:10626-10631.
4. Schmidt D., Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 2003, 60:2561-2574.
5. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 2005, 15:536-541.
6. Sharrocks A.D. PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases?. Genes Dev. 2006, 20:754-758.
7. Long J., Matsuura I., He D., Wang G., Shuai K., Liu F. Repression of Smad transcriptional activity by PIASy an inhibitor of activated STAT. Proc. Natl. Acad. Sci. USA 2003, 100:9791-9796.
8. Tirard M., Jasbinsek J., Almeida O.F., Michaelidis T.M. The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells. J. Mol. Endocrinol. 2004, 32:825-841.
9. Schmidt D., Muller S. Members of the PIAS family act as SUMO-ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 2002, 99:2872-2877.
10. Bischof O., Schwamborn K., Martin N., Werner A., Sustmann C., Grosschedl R., Dejean A. The E3 SUMO-ligase PIASy is a regulator of cellular senescence and apoptosis. Mol. Cell 2006, 22:783-794.
11. Finlan L.E., Hupp T.R. P63: the phantom of the tumor suppressor. Cell Cycle 2007, 6:1062-1071.
12. Laurenzi V.D., Costanzo A., Barcaroli D., Terrinoni A., Falco M., Petruzzelli M.A., Levrero M., Melino G. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 1998, 188:1763-1768.
13. Laurenzi V.D., Raschella G., Barcaroli D., Petruzzelli M.A., Ranalli M., Catani M.V., Tanno B., Costanzo A., Levrero M., Melino G. Induction of neuronal differentiation by p73, in a neuroblastoma cell line. J. Biol. Chem. 2000, 275:15226-15231.
14. Catani M.V., Costanzo A., Savini I., Levrero M., Laurenzi V.D., Wang J.Y., Melino G., Avigliano L. Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage. Biochem. J. 2002, 364:441-447.
15. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36 A region frequently deleted in neuroblastoma and other human cancers. Cell 1997, 90:809-819.
16. Ueda Y., Hijikata M., Takagi S., Chib T., Shimotohno K. New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 1999, 18:4993-4998.
17. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
18. 2 by sumoylation of p73. Mol. Cell. Biol. 2004, 24:10593-10610.
19. Grob T.J., Fey M.F., Tobler A. The two faces of p73. Cell Death Differ. 2002, 9:229-230.
20. Gan X.Q., Wang J.Y., Xi Y., Wu Z.L., Li Y.P., Li L. Nuclear Dvl C-Jun, β-catenin, and TCF form a complex leading to stabilization of β-catenin-TCF interaction. J. Cell Biol. 2008, 180:1087-1100.
21. Rossi M., Laurenzi V.D., Munarriz E., Green D.R., Liu Y.C., Vousden K.H., Cesareni G., Melino G. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 2005, 24:836-848.
22. Deng Z.Y., Wan M.M., Sui G.C. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the ring finger. Mol. Cell. Biol. 2007, 27:3780-3792.
23. Tomoiu A., Gravel A., Tanguay R.M., Flamand L. Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. J. Virol. 2006, 80:10218-10228.
24. Wu Y., Fan Y., Xue B., Luo L., Shen J., Zhang H., Jiang Y., Yin Z. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006, 25:5787-5800.
25. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Henderson C.J., Wolf C.R. Regulation of JNK signaling by GSTp. EMBO J. 1999, 18:1321-1334.
26. Chen L., Kong X.Q., Fu J., Xu Y.M., Fang S.P., Hua P., Luo L., Yin Z.M. CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation. Cell. Immunol. 2009, 258:38-43.
27. Gross M., Liu B., Tan J., French F., Carey M., Shuai K. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 2001, 20:3880-3887.
28. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 2001, 15:3088-3103.
29. Minty A., Dumont X., Kaghad M., Caput D. Covalent modification of p73α by SUMO-1. J. Biol. Chem. 2000, 46:36316-36323.
30. Agami R., Blandino G., Oren M., Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 1999, 399:809-813.
31. Gong J.G., Costanzo A., Yang H.Q., Melino G., Kaelin W.G., Levrero J.M., Wang J.Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999, 399:806-809.
32. Melino G., Laurenzi V.D., Vousden K.H. P73: friend or foe in tumorigenesis. Nat. Rev. Cancer 2002, 2:605-615.
33. Melino G., Lu X., Gasco M., Crook T., Knight R.A. Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 2003, 28:663-670.
34. Matunis M.J., Coutavas E., Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 1996, 135:1457-1470.
35. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?. Genes Dev. 2004, 18:2046-2059.
36. Bergamaschi D. P53 polymorphism influences response in cancer chemotherapy via modulation of p73 dependent apoptosis. Cancer Cell 2003, 3:342-387.
37. Toshinori O., Akira N. P73, a sophisticated p53 family member in cancer world. Cancer Sci. 2005, 79:729-737.
38. Nelson V., Davis G.E., Maxwell S.A. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. Apoptosis 2001, 6:221-234.